Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2020 Jun;81(4):470-490.
doi: 10.1002/ddr.21640. Epub 2020 Jan 14.

Selected pharmacotherapy agents as antiproliferative and anti-inflammatory compounds

Affiliations
Comparative Study

Selected pharmacotherapy agents as antiproliferative and anti-inflammatory compounds

Mthanna AlKhalil et al. Drug Dev Res. 2020 Jun.

Abstract

The repurposing of safe therapeutic drugs has emerged as an alternative approach to rapidly identify effective, safe, and conveniently available therapeutics to treat/prevent cancer. Therefore, it was hypothesized that acidic chelator drugs could have a genuine potential as antiproliferative agents. Based on their pKa, the selected 15 acidic drugs of eight classes-namely sulfonylureas, proton pump inhibitors, fluoroquinolones, nonsteroidal anti-inflammatory agents, thiazolidinediones, thienopyridines, statins, and nicotinic acid-were assayed for anticancer HTS against the lung A549, skin A375, breast MCF7 and T47D, pancreatic PANC1, cervical HeLa, and leukemia K562 cancer cell lines and normal fibroblasts. Lipopolysaccharide-prompted inflammation in RAW264.7 macrophages was the potential anticancer mechanism. Atorvastatin exerted remarkably superior cytotoxicity against A375.2S (IC50 value 0.02 μM p < .001 vs. cisplatin 0.07 μM IC50 value). Atorvastatin exhibited an equipotency to cisplatin's T47D growth inhibition (34.6 μM vs. 34.59 μM; p > .05). Levofloxacin as well as ciprofloxacin superbly superseded the antineoplastic cisplatin activity against the K562 cell line (respective IC50 values [μM] 10.4 and 19.5 vs. 29.3; p < .05-<.01). Gemifloxacin and lansoprazole had comparable antiproliferation in K562 to cisplatin's (respective IC50 values [μM] 34.9 and 36.3 vs. 29.3; p > .05). The selected agents lacked cytotoxicity in the panel of MCF7, HeLa, A549, or Panc1 cancer cells. Most notably, LPS prompted RAW264.7 macrophages, atorvastatin, piroxicam, clopidogrel, esomeprazole, and lansoprazole were of higher anti-inflammation potency than indomethacin (p < .01-.001). Evidently, omeprazole, pioglitazone, gemifloxacin, and indomethacin were of comparable anti-inflammation potencies (p > .05). Collectively, this work reveals acidic chelator drugs (atorvastatin, gemifloxacin, and lansoprazole with dual anti-inflammation and antiproliferation propensities) as authentic agents for the repurposing approach in anticancer chemotherapy/prevention.

Keywords: anti-inflammation; antiproliferation; commercial agents.

PubMed Disclaimer

References

REFERENCES

    1. Abdul Fattah, T., Saeed, A., Al-Hiari, Y. M., Kasabri, V., Almasri, I. M., AlAlawi, S., … Channara, P. A. (2019). Functionalized Furo[3,2-c]coumarins as anti-proliferative, anti-lipolytic, and anti-inflammatory compounds: Synthesis and molecular docking studies. Journal of Molecular Structure, 1179, 390-400.
    1. Abdullah, K., & Altwairgi, A. (2015). Statins are potential anticancerous agents. Oncology Reports, 33, 1019-1039.
    1. Adams, D. J., & Morgan, L. R. (2011). Tumor physiology and charge dynamics of anticancer drugs: Implications for camptothecin-based drug development. Current Medicinal Chemistry, 18(9), 1367-1372.
    1. Aggarwal, B. B. (2009). Inflammation, a silent killer in cancer is not so silent! Current Opinion in Pharmacology, 9, 347-350.
    1. Alabsi, Y., Al-Hiari, Y., Kasabri, V., Arabiyat, S., Bashiti, R., Alalawi, S., & Al-Shahrabi, R. (2018). In vitro modulation of pancreatic lipase and proliferation of obesity related-colorectal cancer cell line panel by novel synthetic fluoroquinolones. Revue Roumaine de Chimie, 63(12), 1123-1134.

Publication types

Substances

LinkOut - more resources